Literature DB >> 24793945

Delayed-type hypersensitivity and hepatitis B vaccine responses, in vivo markers of cellular and humoral immune function, and the risk of AIDS or death.

Shane B Patterson1, Michael L Landrum2, Jason F Okulicz3.   

Abstract

BACKGROUND: Delayed-type hypersensitivity (DTH) test responsiveness is associated with HIV disease progression; however it is unknown whether other immune markers, such as hepatitis B virus (HBV) vaccine seroresponse, also predict HIV outcomes.
METHODS: Eligible participants received HBV vaccine after HIV diagnosis, had non-anergic DTH testing at the time of last HBV vaccination, and available post-vaccine HBV antibody responses. The risk of progression to AIDS or death from the time of last HBV vaccination was evaluated.
RESULTS: Of 369 eligible participants with non-anergic DTH responses, 148 (40%) were HBV vaccine responders. In a multivariate model adjusted for age, CD4 count, viral load, and number of vaccinations, HBV vaccine non-responders had an increased risk of progression to AIDS or death (HR 1.81; 95% CI, 1.03-3.19).
CONCLUSIONS: HBV vaccine seroresponses were independent of DTH responses which suggest that non-response to HBV vaccine is not solely due to cell-mediated immune dysfunction in HIV-infected persons. Published by Elsevier Ltd.

Entities:  

Keywords:  AIDS; Anergy; Delayed-type hypersensitivity; HIV; Hepatitis B vaccine

Mesh:

Substances:

Year:  2014        PMID: 24793945      PMCID: PMC4114337          DOI: 10.1016/j.vaccine.2014.04.049

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation.

Authors:  Loredana Goncalves; Benibelks Albarran; Siham Salmen; Lerida Borges; Howard Fields; Henry Montes; Andres Soyano; Yuleima Diaz; Lisbeth Berrueta
Journal:  Virology       Date:  2004-08-15       Impact factor: 3.616

2.  A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study.

Authors:  A Carr; J Chuah; J Hudson; M French; J Hoy; M Law; D Sayer; S Emery; D A Cooper
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

3.  Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients.

Authors:  S P Blatt; C W Hendrix; C A Butzin; T M Freeman; W W Ward; R E Hensley; G P Melcher; D J Donovan; R N Boswell
Journal:  Ann Intern Med       Date:  1993-08-01       Impact factor: 25.391

4.  CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.

Authors:  Matthew J Dolan; Hemant Kulkarni; Jose F Camargo; Weijing He; Alison Smith; Juan-Manuel Anaya; Toshiyuki Miura; Frederick M Hecht; Manju Mamtani; Florencia Pereyra; Vincent Marconi; Andrea Mangano; Luisa Sen; Rosa Bologna; Robert A Clark; Stephanie A Anderson; Judith Delmar; Robert J O'Connell; Andrew Lloyd; Jeffrey Martin; Seema S Ahuja; Brian K Agan; Bruce D Walker; Steven G Deeks; Sunil K Ahuja
Journal:  Nat Immunol       Date:  2007-10-21       Impact factor: 25.606

5.  Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America.

Authors:  Judith A Aberg; Joel E Gallant; Khalil G Ghanem; Patricia Emmanuel; Barry S Zingman; Michael A Horberg
Journal:  Clin Infect Dis       Date:  2013-11-13       Impact factor: 9.079

6.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18

7.  Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons.

Authors:  S P Blatt; W F McCarthy; B Bucko-Krasnicka; G P Melcher; R N Boswell; J Dolan; T M Freeman; J M Rusnak; R E Hensley; W W Ward
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

8.  In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus.

Authors:  M J Dolan; M Clerici; S P Blatt; C W Hendrix; G P Melcher; R N Boswell; T M Freeman; W Ward; R Hensley; G M Shearer
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

9.  Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study Group.

Authors:  F M Gordin; P M Hartigan; N G Klimas; S B Zolla-Pazner; M S Simberkoff; J D Hamilton
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

10.  The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of HIV-infected patients. Military Medical Consortium for Applied Retroviral Research.

Authors:  D L Birx; J Brundage; K Larson; R Engler; L Smith; E Squire; G Carpenter; M Sullivan; J Rhoads; C Oster
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-11
View more
  3 in total

1.  Telomere and ATM Dynamics in CD4 T-Cell Depletion in Active and Virus-Suppressed HIV Infections.

Authors:  Sushant Khanal; Qiyuan Tang; Dechao Cao; Juan Zhao; Lam Nhat Nguyen; Oluwayomi Samson Oyedeji; Xindi Dang; Lam Ngoc Thao Nguyen; Madison Schank; Bal Krishna Chand Thakuri; Chinyere Ogbu; Zheng D Morrison; Xiao Y Wu; Zheng Zhang; Qing He; Mohamed El Gazzar; Zhengke Li; Shunbin Ning; Ling Wang; Jonathan P Moorman; Zhi Q Yao
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

2.  Immune Response to Hepatitis B Virus Vaccine Among People Living With HIV: A Meta-Analysis.

Authors:  Yakun Tian; Wei Hua; Yaxin Wu; Tong Zhang; Wen Wang; Hao Wu; Caiping Guo; Xiaojie Huang
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

3.  ATM Deficiency Accelerates DNA Damage, Telomere Erosion, and Premature T Cell Aging in HIV-Infected Individuals on Antiretroviral Therapy.

Authors:  Juan Zhao; Lam Ngoc Thao Nguyen; Lam Nhat Nguyen; Xindi Dang; Dechao Cao; Sushant Khanal; Madison Schank; Bal Krishna Chand Thakuri; Stella C Ogbu; Zheng D Morrison; Xiao Y Wu; Zhengke Li; Yue Zou; Mohamed El Gazzar; Shunbin Ning; Ling Wang; Jonathan P Moorman; Zhi Q Yao
Journal:  Front Immunol       Date:  2019-11-05       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.